孕期孕产妇肥胖和高血压的病理生理学
Joana Lourenço1,2, Luís Guedes-Martins1,2,3,4,5
1Instituto de Ciências Biomédicas Abel Salazar, University of Porto, 4050-313 Porto, Portugal.
Journal of cardiovascular development and disease
|March 26, 2025
概括
孕产妇的肥胖明显增加了妊娠高血压疾病 (HDPs) 的风险,包括孕前. 本综述探讨了肥胖相关的代谢变化如何导致这些严重的妊娠并发症.
科学领域:
- 产科和妇科 产科和妇科
- 生殖健康 生殖健康
- 公共卫生 公共卫生
背景情况:
- 肥胖是一个主要的全球健康问题,特别影响生育年龄的女性.
- 孕产妇的肥胖与母亲和胎儿的不良结果有关.
- 妊娠高血压疾病 (HDPs) 的风险增加,如妊娠高血压和先兆子,是一个关键问题.
研究的目的:
- 审查关于母亲肥胖症并发症的科学文献.
- 评估孕产妇肥胖和HDPs发展之间的关联.
- 阐明肥胖在HDPs病理生理学中的作用.
主要方法:
- 对现有的科学文献进行系统审查.
- 对调查母亲肥胖和怀孕结果的研究进行分析.
- 探索参与HDP发育的代谢和炎症途径.
主要成果:
- 在怀孕前的体重指数 (BMI) 和子宫前 (PE) 风险之间存在线性关联.
- 过度的妊娠体重增加也与PE和妊娠高血压 (GH) 有关.
- 与肥胖相关的新陈代谢障碍,如胰岛素耐药性,低胺菌血症和炎症,在HDP病变发生中起着中心作用.
结论:
- 孕产妇的肥胖是HDPs的一个关键风险因素.
- 肥胖引起的内皮功能障碍,由阿迪波金和代谢障碍驱动,对PE有显著的贡献.
- 了解这些机制对于管理和预防肥胖孕妇的HDP至关重要.
关键词:
埃克拉姆普西亚 (eclampsia) 是一种对身体的影响.孕期高血压是什么意思这种高血压,高血压.怀孕期间的高血压疾病.孕产妇的肥胖症 母亲的肥胖症孕产妇产前炎症 (pre-eclampsia) 是一个严重的疾病.怀孕 怀孕 怀孕 怀孕 怀孕更多相关视频
05:17Author Spotlight: Enhancing the Offspring Health in Rats with Maternal Exercise During Pregnancy
Published on: April 5, 2024
660
05:31Author Spotlight: Modeling an Aspect of Preeclampsia in Female Mice Using Hypoxic Human Placenta-Derived Small Extracellular Vesicles
Published on: January 26, 2024
729
相关概念视频
Pathophysiology of Diabetes
833
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
833
Hormonal Regulation
32.8K
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
32.8K
Obesity
353
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
353
Diabetes Mellitus: Type 2 and Gestational
2.1K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.1K
Hypertension and Regulation of Blood Pressure
1.9K
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
1.9K
Teratogenicity
2.3K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.3K
